| 1 |
Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2 143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion[J]. Lancet, 2005, 366 (9488): 809-817.
|
| 2 |
Sani S, Jobe KW, Lopes DK. Treatment of wide-necked cerebral aneurysms with the Neuroform2 Treo stent. A prospective 6-month study[J]. Neurosurg Focus, 2005, 18 (2): E4.
|
| 3 |
Henkes H, Bose A, Felber S, et al. Endovascular coil occlusion of intracranial aneurysms assisted by a novel self-expandable nitinol microstent (neuroform)[J]. Interv Neuroradiol, 2002, 8 (2): 107-119.
|
| 4 |
Bendok BR, Parkinson RJ, Hage ZA, et al. The effect of vascular reconstruction device-assisted coiling on packing density, effective neck coverage, and angiographic outcome: an in vitro study[J]. Neurosurgery, 2007, 61 (4): 835-840; discussion 840-841.
|
| 5 |
Benitez RP, Silva MT, Klem J, et al. Endovascular occlusion of wide-necked aneurysms with a new intracranial microstent (Neuroform) and detachable coils[J]. Neurosurgery, 2004, 54 (6): 1359-1367; discussion 1368.
|
| 6 |
Mocco J, Fargen KM, Albuquerque FC, et al. Delayed thrombosis or stenosis following enterprise-assisted stent-coiling: is it safe? Midterm results of the interstate collaboration of enterprise stent coiling[J]. Neurosurgery, 2011, 69 (4): 908-913; discussion 913-914.
|
| 7 |
Kanaan H, Jankowitz B, Aleu A, et al. In-stent thrombosis and stenosis after neck-remodeling device-assisted coil embolization of intracranial aneurysms[J]. Neurosurgery, 2010, 67 (6): 1523-1532; discussion 1532-1533.
|
| 8 |
Piotin M, Blanc R, Spelle L, et al. Stent-assisted coiling of intracranial aneurysms: clinical and angiographic results in 216 consecutive aneurysms[J]. Stroke, 2010, 41 (1): 110-115.
|
| 9 |
Amenta PS, Dalyai RT, Kung D, et al. Stent-assisted coiling of wide-necked aneurysms in the setting of acute subarachnoid hemorrhage: experience in 65 patients[J]. Neurosurgery, 2012, 70 (6): 1415-1429; discussion 1429.
|
| 10 |
Moser M, Bertram U, Peter K, et al. Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates[J]. J Cardiovasc Pharmacol, 2003, 41 (4): 586-592.
|
| 11 |
Li Y, Spencer FA, Ball S, et al. Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein Ⅱb/Ⅲa receptor-directed antagonists: potential contributing mechanism of benefit in acute coronary syndromes[J]. J Thromb Thrombolysis, 2000, 10 (1): 69-76.
|
| 12 |
Ciccone A, Motto C, Abraha I, et al. Glycoprotein Ⅱb-Ⅲa inhibitors for acute ischaemic stroke[J]. Cochrane Database Syst Rev, 2014 (3): CD005208.
|
| 13 |
Zhao W, Che R, Shang S, et al. Low-dose tirofiban improves functional outcome in acute ischemic stroke patients treated with endovascular thrombectomy[J]. Stroke, 2017, 48 (12): 3289-3294.
|
| 14 |
Siebler M, Hennerici MG, Schneider D, et al. Safety of tirofiban in acute ischemic stroke: the SaTIS trial[J]. Stroke, 2011, 42 (9): 2388-2392.
|
| 15 |
Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group[J]. Stroke, 2010, 41 (10): 2391-2395.
|
| 16 |
Sanelli PC, Kishore S, Gupta A, et al. Delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: proposal of an evidence-based combined clinical and imaging reference standard[J]. AJNR Am J Neuroradiol, 2014, 35 (12): 2209-2214.
|
| 17 |
中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治指南2010[J/CD]. 中国医学前沿杂志（电子版），2010，2(4)：50-59，69.
|
| 18 |
Medical Advisory Secretariat. Coil embolization for intracranial aneurysms: an evidence-based analysis[J]. Ont Health Technol Assess Ser, 2006, 6 (1): 1-114.
|
| 19 |
Derdeyn CP, Cross DT 3rd, Moran CJ, et al. Post-procedure ischemic events after treatment of intracranial aneurysms with Guglielmi detachable coils[J]. J Neurosurg, 2002, 96 (5): 837-843.
|
| 20 |
Qureshi AI, Luft AR, Sharma M, et al. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: part Ⅱ--clinical aspects and recommendations[J]. Neurosurgery, 2000, 46 (6): 1360-1375; discussion 1375-1376.
|
| 21 |
Akpek S, Arat A, Morsi H, et al. Self-expandable stent-assisted coiling of wide-necked intracranial aneurysms: a single-center experience[J]. AJNR Am J Neuroradiol, 2005, 26 (5): 1223-1231.
|
| 22 |
Mordasini P, Walser A, Gralla J, et al. Stent placement in the endovascular treatment of intracranial aneurysms[J]. Swiss Med Wkly, 2008, 138 (43-44): 646-654.
|
| 23 |
Yi HJ, Gupta R, Jovin TG, et al. Initial experience with the use of intravenous eptifibatide bolus during endovascular treatment of intracranial aneurysms[J]. AJNR Am J Neuroradiol, 2006, 27 (9): 1856-1860.
|
| 24 |
Baik SK, Oh SJ, Park KP, et al. Intra-arterial tirofiban infusion for partial recanalization with stagnant flow in hyperacute cerebral ischemic stroke[J]. Interv Neuroradiol, 2011, 17 (4): 442-451.
|
| 25 |
冯学问，陈智才，钟根龙，等. 急性缺血性卒中患者血管内治疗后应用替罗非班的安全性及预后分析[J]. 浙江大学学报（医学版），2017，46(4)：397-404.
|
| 26 |
Park JH, Kim JE, Sheen SH, et al. Intraarterial abciximab for treatment of thromboembolism during coil embolization of intracranial aneurysms: outcome and fatal hemorrhagic complications[J]. J Neurosurg, 2008, 108 (3): 450-457.
|
| 27 |
Bird JE, Giancarli MR, Allegretto N, et al. Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis[J]. Thromb Res, 2008, 123 (1): 146-158.
|